Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells

被引:6
|
作者
Yu-xiu LI
机构
关键词
<Keyword>hepatocellular carcinoma; 5-Fluorouracil; drag resistance; apoptosis; p53; genes; transfection;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM: To study the effect of wild type (wt) p53 gene transfection on drug resistant human hepatocellular carcinoma (HCC) cells induced by 5-Fluorouracil (5-FU). METHODS: The cytotoxicity of anticancer drugs on Bel7402 and Bel7402/5-FU cells was assessed using SRB assay. p53 expression was detected at its mRNA level by RT-PCR assay and at its protein level Western blot or immunocytochemistry assay in Bel7402/5-FU cells transfected with either control vector or wt p53. AnnexinV-FITC/PI double labeled assay was performed to detect apoptosis. The chemosensitivity of Bel7402/5-FU cells transfected with wt p53 was assessed using SRB assay. RESULTS: Bel7402/ 5-FU cells exhibited cross-resistance to vincristine, doxorubicin, paclitaxel, and so on. wt p53 gene transfection upregulated the expression of p53 in Bel7402/5-FU cells. wt p53 was able to greatly inhibit cell
引用
收藏
页码:78 / 84
页数:7
相关论文
共 50 条
  • [21] Expression of p53, BclX, and Bak apoptotic regulatory proteins in 5-FU resistant colonic carcinoma hepatic metastases
    Liu, DF
    Fergusson, K
    Mulligan, D
    Cooper, G
    Markowitz, S
    Willis, J
    GASTROENTEROLOGY, 1999, 116 (04) : A455 - A455
  • [22] Epigenetic silencing BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU
    Li, Xin
    Yu, Jie
    Brock, Malcolm
    Tao, Qian
    Herman, James
    Liang, Ping
    Guo, Mingzhou
    CANCER RESEARCH, 2015, 75
  • [23] Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU
    Li, Xin
    Yu, Jie
    Brock, Malcolm V.
    Tao, Qian
    Herman, James G.
    Liang, Ping
    Guo, Mingzhou
    ONCOTARGET, 2015, 6 (13) : 11547 - 11560
  • [24] Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
    Xu, GW
    Sun, ZT
    Forrester, K
    Wang, XW
    Coursen, J
    Harris, CC
    HEPATOLOGY, 1996, 24 (05) : 1264 - 1268
  • [25] Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene
    Kimura, M
    Tagawa, M
    Takenaga, K
    Yamaguchi, T
    Saisho, H
    Nakagawara, A
    Sakiyama, S
    ANTICANCER RESEARCH, 1997, 17 (2A) : 879 - 883
  • [26] MiR-122上调野生p53蛋白增强BEL-7402/5-FU细胞对5-氟尿嘧啶敏感性
    殷杰
    杨晓燕
    虞佳
    向琼
    朱炳阳
    雷小勇
    中南医学科学杂志, 2011, 39 (06) : 640 - 642+658
  • [27] Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells
    Shin-ichi Osaki
    Yoichi Nakanishi
    Koichi Takayama
    Xin-Hai Pei
    Hikaru Ueno
    Nobuyuki Hara
    Cancer Gene Therapy, 2000, 7 : 300 - 307
  • [28] Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
    Toshinori Ozaki
    Meng Yu
    Danjing Yin
    Dan Sun
    Yuyan Zhu
    Youquan Bu
    Meixiang Sang
    BMC Cancer, 18
  • [29] Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
    Ozaki, Toshinori
    Yu, Meng
    Yin, Danjing
    Sun, Dan
    Zhu, Yuyan
    Bu, Youquan
    Sang, Meixiang
    BMC CANCER, 2018, 18
  • [30] Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells
    Osaki, S
    Nakanishi, Y
    Takayama, K
    Pei, XH
    Ueno, H
    Hara, N
    CANCER GENE THERAPY, 2000, 7 (02) : 300 - 307